Written Question·Department of Health and Social Care·UIN HL4917

Tabled: 4 November 2026

Question

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 2 November (HL4193), whether she intends to publish the safety evaluation report for vortioxetine submitted by a marketing authorisation holder that is currently being as